头颈癌相关淋巴水肿的康复干预:一项系统综述
该系统综述检索5个电子数据库至2023年1月3日,纳入23项研究(2147例患者),其中6项为随机临床试验、17项为观察性研究。低质量证据提示标准淋巴水肿治疗有益,高质量证据支持肌内效贴作为辅助治疗,低质量证据提示先进气压压缩装置可能有益。作者认为需更多前瞻性、对照、有足够把握度的研究明确理想干预方案。
要点
- 标准淋巴水肿治疗尤其门诊环境和至少部分依从时,低质量证据提示有益。
- 肌内效贴作为辅助治疗获高质量证据支持。
- 先进气压压缩装置可能有益,但证据质量低。
核心结论
- 头颈癌相关淋巴水肿的康复干预(包括标准淋巴水肿治疗、肌内效贴和先进气压压缩装置)似乎安全且有益。
- 需要更多前瞻性、对照、有足够把握度的研究明确淋巴水肿治疗组成部分的理想类型、时机、持续时间和强度,之后才能建立治疗指南。
研究设计与样本
- 系统综述,检索5个电子数据库自建库至2023年1月3日,由2名独立评价者进行筛选、数据提取、质量评级和偏倚风险评估。
- 共识别1642条引文,纳入23项研究(1.4%,n=2147例患者),其中6项(26.1%)为随机临床试验,17项(73.9%)为观察性研究。
- 6项随机临床试验中5项发表于2020年至2022年;大多数研究参与者少于50例(6项随机临床试验中5项,17项观察性研究中13项)。
主要发现
- 研究按干预类型分类:标准淋巴水肿治疗11项(47.8%),辅助治疗12项(52.2%)。
- 标准淋巴水肿治疗包括标准完全减充血治疗(2项随机临床试验、5项观察性研究)、改良完全减充血治疗(3项观察性研究)、治疗环境(1项随机临床试验、2项观察性研究)、依从性(2项观察性研究)、早期手动淋巴引流(1项随机临床试验)和包含聚焦运动(1项随机临床试验)。
- 辅助治疗包括先进气压压缩装置(1项随机临床试验、5项观察性研究)、肌内效贴(1项随机临床试验)、光生物调节(1项观察性研究)、针灸/艾灸(1项观察性研究)和亚硒酸钠(1项随机临床试验、2项观察性研究)。
- 严重不良事件未发现(9项,39.1%)或未报告(14项,60.9%)。
- 低质量证据提示标准淋巴水肿治疗有益,尤其在门诊环境和至少部分依从时;高质量证据支持肌内效贴作为辅助治疗;低质量证据提示先进气压压缩装置可能有益。
关键数值与推荐
- 严重不良事件:未发现9项(39.1%),未报告14项(60.9%)。
- 证据质量:标准淋巴水肿治疗为低质量证据;肌内效贴辅助治疗为高质量证据;先进气压压缩装置为低质量证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 大多数研究参与者少于50例(6项随机临床试验中5项,17项观察性研究中13项)。
- 需要更多前瞻性、对照、有足够把握度的研究明确淋巴水肿治疗组成部分的理想类型、时机、持续时间和强度,之后才能建立治疗指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Head and neck cancer-associated lymphedema (HNCaL) affects up to 90% of survivors of head and neck cancer and is a substantial contributor to disability following head and neck cancer treatment. Despite the prevalence and morbidity associated with HNCaL, rehabilitation interventions are not well studied. OBJECTIVE: To identify and appraise the current evidence for rehabilitation interventions in HNCaL. EVIDENCE REVIEW: Five electronic databases were searched systematically from inception to January 3, 2023, for studies on HNCaL rehabilitation interventions. Study screening, data extraction, quality rating, and risk of bias assessment were performed by 2 independent reviewers. FINDINGS: Of 1642 citations identified, 23 studies (1.4%; n = 2147 patients) were eligible for inclusion. Six studies (26.1%) were randomized clinical trials (RCTs) and 17 (73.9%) were observational studies. Five of the 6 RCTs were published during 2020 to 2022. Most studies had fewer than 50 participants (5 of 6 RCTs; 13 of 17 observational studies). Studies were categorized by intervention type, including standard lymphedema therapy (11 studies [47.8%]) and adjunct therapy (12 studies [52.2%]). Lymphedema therapy interventions included standard complete decongestive therapy (CDT) (2 RCTs, 5 observational studies), modified CDT (3 observational studies), therapy setting (1 RCT, 2 observational studies), adherence (2 observational studies), early manual lymphatic drainage (1 RCT), and inclusion of focused exercise (1 RCT). Adjunct therapy interventions included advanced pneumatic compression devices (APCDs) (1 RCT, 5 observational studies), kinesio taping (1 RCT), photobiomodulation (1 observational study), acupuncture/moxibustion (1 observational study), and sodium selenite (1 RCT, 2 observational studies). Serious adverse events were either not found (9 [39.1%]) or not reported (14 [60.9%]). Low-quality evidence suggested the benefit of standard lymphedema therapy, particularly in the outpatient setting and with at least partial adherence. High-quality evidence was found for adjunct therapy with kinesio taping. Low-quality evidence also suggested that APCDs may be beneficial. CONCLUSIONS AND RELEVANCE: The results of this systematic review suggest that rehabilitation interventions for HNCaL, including standard lymphedema therapy with kinesio taping and APCDs, appear to be safe and beneficial. However, more prospective, controlled, and adequately powered studies are needed to clarify the ideal type, timing, duration, and intensity of lymphedema therapy components before treatment guidelines can be established.
引用
- Cheng JT, Leite VF, Tennison JM, et al. Rehabilitation Interventions for Head and Neck Cancer-Associated Lymphedema: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37382963. doi:10.1001/jamaoto.2023.1473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。